Central Trust Company’s NuVasive, Inc. NUVA Stock Holding History

Central Trust Company’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-70	Closed	-$4K	–	1148
2020 Q4	$4K	Sell	70 -20	-22%	-$984	﹤0.01%	1011
2020 Q3	$4K	Sell	90 -10	-10%	-$539	﹤0.01%	973
2020 Q2	$6K	Buy	+100	New	+$5.78K	﹤0.01%	913
2017 Q3	–	Sell	-20	Closed	-$2K	–	1379
2017 Q2	$2K	Sell	20 -652	-97%	-$48.7K	﹤0.01%	1174
2017 Q1	$50K	Hold	672	–	–	﹤0.01%	718
2016 Q4	$45K	Sell	672 -105	-14%	-$6.77K	﹤0.01%	729
2016 Q3	$52K	Buy	+777	New	+$49.5K	﹤0.01%	670

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Central Trust Company's NUVA Position: Q1 2021 in Review

Central Trust Company sold out of NuVasive, Inc. (NUVA) in Q1 2021, closing a stake of 70 shares — an estimated $4K sold.

Central Trust Company first reported a position in NUVA in Q3 2016 and held it in 7 quarters. The position peaked at $52K in Q3 2016. 261 funds tracked by Wall St. Rank hold NUVA as of Q1 2021.

Central Trust Company reported no remaining NuVasive, Inc. position as of Q1 2021 after selling out during the quarter.
Central Trust Company sold 70 NuVasive, Inc. shares in Q1 2021, an estimated $4K.
Central Trust Company first reported a position in NuVasive, Inc. in Q3 2016 and held it in 7 quarters.
Central Trust Company's NuVasive, Inc. position peaked at $52K in Q3 2016.
261 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2021.

Based on Central Trust Company's 13F filing for Q1 2021, filed 23 Apr 2021.